HUE045355T2 - Az 5-HT7 szerotoninreceptort kötõ imidazolil-szubsztituált indolszármazékok és gyógyszerészeti készítményeik - Google Patents

Az 5-HT7 szerotoninreceptort kötõ imidazolil-szubsztituált indolszármazékok és gyógyszerészeti készítményeik

Info

Publication number
HUE045355T2
HUE045355T2 HUE16461543A HUE16461543A HUE045355T2 HU E045355 T2 HUE045355 T2 HU E045355T2 HU E16461543 A HUE16461543 A HU E16461543A HU E16461543 A HUE16461543 A HU E16461543A HU E045355 T2 HUE045355 T2 HU E045355T2
Authority
HU
Hungary
Prior art keywords
imidazolyl
pharmaceutical compositions
serotonin receptor
indole derivatives
substituted indole
Prior art date
Application number
HUE16461543A
Other languages
English (en)
Inventor
Adam Hogendorf
Agata Hogendorf
Grzegorz Satala
Rafal Kurczab
Ryszard Bugno
Jakub Staron
Tomasz Lenda
Andrzej J Bojarski
Original Assignee
Inst Farmakologii Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Farmakologii Polskiej Akademii Nauk filed Critical Inst Farmakologii Polskiej Akademii Nauk
Publication of HUE045355T2 publication Critical patent/HUE045355T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE16461543A 2016-07-21 2016-07-21 Az 5-HT7 szerotoninreceptort kötõ imidazolil-szubsztituált indolszármazékok és gyógyszerészeti készítményeik HUE045355T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16461543.7A EP3272745B1 (en) 2016-07-21 2016-07-21 Imidazolyl-substituted indole derivatives binding 5-ht7 serotonin receptor and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
HUE045355T2 true HUE045355T2 (hu) 2019-12-30

Family

ID=56507560

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16461543A HUE045355T2 (hu) 2016-07-21 2016-07-21 Az 5-HT7 szerotoninreceptort kötõ imidazolil-szubsztituált indolszármazékok és gyógyszerészeti készítményeik

Country Status (12)

Country Link
US (1) US10844046B2 (hu)
EP (1) EP3272745B1 (hu)
CN (1) CN109641877B (hu)
AU (1) AU2017300841B2 (hu)
CA (1) CA3031006A1 (hu)
DK (1) DK3272745T3 (hu)
ES (1) ES2744720T3 (hu)
HR (1) HRP20191532T1 (hu)
HU (1) HUE045355T2 (hu)
PL (1) PL3272745T3 (hu)
PT (1) PT3272745T (hu)
WO (1) WO2018015558A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019136558A1 (en) * 2018-01-10 2019-07-18 University Health Network Inhibitor of indoleamine 2,3-dioxygenase-1 and methods of manufacture and use thereof
CN112174937B (zh) * 2020-10-19 2022-06-03 南京农业大学 3-(5-咪唑基)吲哚类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
DE19948417A1 (de) 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
WO2008119741A2 (en) * 2007-03-29 2008-10-09 Novartis Ag 3-imidazolyl-indoles for the treatment of proliferative diseases

Also Published As

Publication number Publication date
ES2744720T3 (es) 2020-02-26
CN109641877A (zh) 2019-04-16
DK3272745T3 (da) 2019-09-02
HRP20191532T1 (hr) 2019-11-29
EP3272745B1 (en) 2019-06-26
US10844046B2 (en) 2020-11-24
US20190284169A1 (en) 2019-09-19
AU2017300841B2 (en) 2021-09-09
CA3031006A1 (en) 2018-01-25
CN109641877B (zh) 2021-09-21
PT3272745T (pt) 2019-09-27
WO2018015558A1 (en) 2018-01-25
PL3272745T3 (pl) 2020-01-31
EP3272745A1 (en) 2018-01-24
AU2017300841A1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
IL282584B (en) History of quinoline and pharmaceutical preparations containing them
HK1259145A1 (zh) 3-脫氧衍生物及其藥物組合物
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
IL258082B (en) History of benzaimidazole and pharmaceutical preparations containing them
ZA201806482B (en) Substituted indoline derivatives as dengue viral replication inhibitors
IL261943A (en) Transformed indulin derivatives as inhibitors of dengue virus replication
HUE054379T2 (hu) Helyettesített indolin-származékok mint a dengue vírus szaporodásának inhibitorai
PL3412660T3 (pl) Pochodna sulfonamidowa i zawierająca ją kompozycja farmaceutyczna
IL249803A0 (en) History of azafenil and pharmaceutical preparations containing them
IL270616B (en) Nitrogen-substituted indoles
PT3606511T (pt) Composição farmacêutica compreendendo mesilato de lenvatinib
IL249308A0 (en) The history of quinoline, their preparation and pharmaceutical preparations containing them
IL248773B (en) History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them
PT3272745T (pt) Derivados de indol substituídos com imidazolilo que se ligam ao recetor de serotonina 5-ht7 e composições farmacêuticas dos mesmos
PT3288933T (pt) Compostos oxindol e composições farmaceuticas do mesmo
HK1257129A1 (zh) 含有吲哚衍生物的藥物組合物、其製備方法和用途
ZA201908398B (en) N-substituted indole derivatives
HK1244703A1 (zh) 一種含有咪唑啉類衍生物的藥物組合物